Letters

Alan Nixon's essay struck in me a sympathetic chord. The issue with which he dealt, the propriety of using data obtained by the Nazis under inhuman conditions, is certainly a provocative one which invites the weighing of moral issues (whether we condone the mode of experimentation) vs. scientific and more important human welfare considerations. I share with Nixon the belief that we cannot undo these dreadful acts of carnage but that we can make amends for them by deriving information of use in

Written byWells Farnsworth
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Alan Nixon's essay struck in me a sympathetic chord. The issue with which he dealt, the propriety of using data obtained by the Nazis under inhuman conditions, is certainly a provocative one which invites the weighing of moral issues (whether we condone the mode of experimentation) vs. scientific and more important human welfare considerations. I share with Nixon the belief that we cannot undo these dreadful acts of carnage but that we can make amends for them by deriving information of use in relieving human suffering. Permit me to briefly clarify my point.

Another atrocious activity of the Nazis was their experimental hypothermia trials, wherein prisoners underwent immersion in ice water. Dreadful though this was, the data obtained have proven of great value in applied physiology and especially in the management of accidental hypothermia. They contributed very significantly, for example, to the successful recovery of a youngster who fell into ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies